Navigation Links
California Stem Cell Agency Proposes Unjustified Increase in Top Salary Ranges
Date:2/19/2008

Agency's Counsel Already Received $65,000 Raise After 10 Months On Job, Topping State AG's Pay

SANTA MONICA, Calif., Feb. 19 /PRNewswire-USNewswire/ -- The California stem cell agency is proposing raising salary ranges for top employees a whopping 50 percent, an increase that is unjustified in the face of a state budget crisis, the Foundation for Taxpayer and Consumer Rights (FTCR) said today.

The proposal, to be considered by the stem cell agency's Governance Committee on Wednesday, comes after a $65,000, 41 percent, pay raise given to the agency's general counsel, Tamar Pachter, in December after 10 months on the job. With the increase Pachter now makes $225,000, more than state Attorney General Jerry Brown's annual salary of $184,301. Pachter was a state deputy attorney general when she was hired by the California Institute for Regenerative Medicine (CIRM) last spring at a salary of $160,000.

"They are demonstrating a particularly tone-deaf action at a time when the state faces a serious budget crisis," said John M. Simpson, FTCR Stem Cell Project Director. "These salaries and proposed ranges are simply too high for an agency that when fully staffed will have a total of 50 employees. For comparison, the governor's salary is set at $212,179."

The Governance Committee is being asked to set the top salary range for the oversight committee chairman and the agency's president at $618,750, a 50 percent increase from the current top of $412,500. The new president, Alan Trounson, is being paid $490,000, an amount already above the current official range of $275,000 to $412,500. Chairman Robert Klein has declined to take a salary.

The proposal would increase the counsel's salary range from $150,000 to $225,000 to a new range of $150,000 to $337,500.

"CIRM doesn't operate with some financier's private stash of cash," said Simpson. "CIRM is a state agency funded by taxpayer dollars. It needs to act like one."

Proposition 71, passed by 59 percent of Californians in 2004, created the stem cell institute. FTCR's Stem Cell Oversight and Accountability Project is working to ensure that California's landmark stem cell research program offers accessible and affordable cures and treatments to the taxpayers who have funded it. The program will sell $3 billion in bonds over a decade to fund stem cell research. Financing charges mean the project, the largest source of stem cell research funding in the world, will cost California taxpayers $6 billion.

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org.


'/>"/>
SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AMA Foundation Honors Oakland, California Physician for Volunteerism
2. The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology
3. Southern California Hospital System Sues Kaiser Permanente for Managing Bills Rather Than Managing Care
4. Blue Cross of California Statement
5. Latest Salvo Fired in Frozen Yogurt Wars as Southern Californias Fastest-Growing Franchise - Cefiore - Launches New Chocolate Flavor
6. Cord Blood America Supports Trend From New York, California for States to Inform Parents of the Advantages of Umbilical Cord Blood Storage
7. California Department of Social Services Announces Improved Access to Disability Payments to Homeless Individuals
8. HealthCare Partners Physicians Join Blue Cross of California Power Select HMO Network
9. Los Angeles Daily Journal Names Richardson & Patel Verdict Top in the State of California for 2007
10. Fi-Med Management, Inc. Acquires California and Utah-based Mediplete, Looks Ahead to Another Year of Growth
11. California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: